Philip A. Downing's most recent trade in Inotiv Inc was a trade of 2,000 Common Shares done at an average price of $24.0 . Disclosure was reported to the exchange on Feb. 22, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inotiv Inc | Philip A. Downing | Sr. VP, Preclinical Srvcs. | Purchase of securities on an exchange or from another person at price $ 23.97 per share. | 22 Feb 2022 | 2,000 | 42,195 (0%) | 0% | 24.0 | 47,946 | Common Shares |
| Inotiv Inc | Philip A. Downing | Sr. VP, Preclinical Srvcs. | Sale of securities on an exchange or to another person at price $ 43.04 per share. | 22 Dec 2021 | 3,057 | 40,195 (0%) | 0% | 43.0 | 131,577 | Common Shares |
| Inotiv Inc | Philip A. Downing | Sr. VP, Preclinical Srvcs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 1,087 | 43,252 (0%) | 0% | 0 | Common Shares | |
| Inotiv Inc | Philip A. Downing | Sr. VP, Preclinical Srvcs. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 7,964 | 42,165 (0%) | 0% | 0 | Common Shares |